FDA approves naloxone nasal spray to reverse opioid overdose
Image courtesy of ADAPT Pharma, Inc.
Easy-to-use technology provides alternative to injectable form of lifesaving medication
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that intranasal naloxone –a nasal spray formulation of the...
Source: NIDA News - Category: Addiction Tags: Health and Medical Professionals, Heroin, Opioids, Pain Medication, Prescription Drugs, Treatment Research Source Type: news
More News: Addiction | Health | National Institutes of Health (NIH) | Overdose | Pain | Pharmaceuticals | Substance Abuse